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Abstract
Berberine, an isoquinoline alkaloid derived from plants, is a traditional medicine for treating bacterial diarrhea and intestinal
parasite infections. Although berberine has recently been shown to suppress growth of several tumor cell lines, information
regarding the effect of berberine on colon tumor growth is limited. Here, we investigated the mechanisms underlying the
effects of berberine on regulating the fate of colon tumor cells, specifically the mouse immorto-Min colonic epithelial (IMCE)
cells carrying the Apc
min mutation, and of normal colon epithelial cells, namely young adult mouse colonic epithelium
(YAMC) cells. Berberine decreased colon tumor colony formation in agar, and induced cell death and LDH release in a time-
and concentration-dependent manner in IMCE cells. In contrast, YAMC cells were not sensitive to berberine-induced cell
death. Berberine did not stimulate caspase activation, and PARP cleavage and berberine-induced cell death were not
affected by a caspase inhibitor in IMCE cells. Rather, berberine stimulated a caspase-independent cell death mediator,
apoptosis-inducing factor (AIF) release from mitochondria and nuclear translocation in a ROS production-dependent
manner. Amelioration of berberine-stimulated ROS production or suppression of AIF expression blocked berberine-induced
cell death and LDH release in IMCE cells. Furthermore, two targets of ROS production in cells, cathepsin B release from
lysosomes and PARP activation were induced by berberine. Blockage of either of these pathways decreased berberine-
induced AIF activation and cell death in IMCE cells. Thus, berberine-stimulated ROS production leads to cathepsin B release
and PARP activation-dependent AIF activation, resulting in caspase-independent cell death in colon tumor cells. Notably,
normal colon epithelial cells are less susceptible to berberine-induced cell death, which suggests the specific inhibitory
effects of berberine on colon tumor cell growth.
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Introduction
Berberine is an isoquinoline alkaloid isolated from several
plants, such as Hydrastis canadensis (goldenseal), Berberis aquifolium
(oregon grape), and Berberis vulgaris (barberry). Berberine has been
used to treat bacteria-associated diarrhea, intestinal parasitic
infections, and ocular trachoma infections for several decades
through its antimicrobial activities [1]. Various beneficial effects of
berberine on several diseases have also been reported. For
example, berberine’s immunoregulatory potential has been
demonstrated by inhibiting HIV protease inhibitor-induced TNF
and IL-6 production in macrophages [2], enhancing progression
of type 1 diabetes in mice, and decreasing Th17 and Th1 cell
differentiation and cytokine production [3]. Other effects of
berberine on diseases include reducing cholesterol levels in
humans and hamsters by elevating LDL receptor expression [4],
inhibiting hepatic gluconeogenesis to improve glucose metabolism
in diabetic rats [5], and reducing the permeability of the blood-
brain barrier and attenuating autoimmune encephalomyelitis in
mice [6].
Recently, increasing evidence supports the inhibitory effect of
berberine on growth of broad tumor cell types derived from bone
marrow, liver, lung, gastrointestinal tract, oral, skin, brain, bone,
bladder, breast, cervix, and prostate [7,8]. Several mechanisms
have been reported for berberine’s antitumor activity. Berberine
has been shown to suppress cancer cell growth and proliferation by
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apoptosis, reduce Bcl-2 and Bcl-xL levels and increase Bax and
Bak levels, and inhibit metastasis by downregulating matrix
metalloproteinases. Signaling pathways involved in anti-cancer
effects of berberine include p53, MAPK, and NF-kB [7,8]. These
findings indicate the multiple mechanisms involved in anti-cancer
effects of berberine on different tumor cell types.
Apoptosis, occurring in a caspase-dependent manner, is the
best-known modality of programmed cell death. Two canonical
pathways have been shown to regulate caspase-dependent
apoptosis, extrinsic ‘‘death-receptor-mediated’’ and intrinsic
‘‘mitochondrial-mediated’’ [9]. The extrinsic pathway includes
recruitment of adaptor molecules that activate caspase-2, -8 or -10.
For the intrinsic pathway, mitochondrial outer membrane
permeabilization causes cytochrome -c release, which binds
caspase-9 to assemble a cytoplasmic complex called the apopto-
some. These two pathways converge in the activation of caspase-3
and/or caspase-6 and -7. Both extrinsic and intrinsic apoptotic
pathways are associated with the activation of caspase-activated
DNase, which generates nuclear oligonucleosomal DNA fragmen-
tation [9,10].
Programmed cell death can also occur through an alternative
mitochondrial route, which is independent of caspase activation
[11]. In this case, loss of mitochondrial function results in release
of mitochondrial proteins to induce cell death without activation of
caspases. Apoptosis-inducing factor (AIF), a mitochondrial oxido-
reductase, is one of the best-studied mediators stimulating caspase-
independent cell death [12,13]. AIF localizes normally in the
intermembrane space of mitochondria. Upon cellular insult, AIF is
cleaved by activated poly (ADP-ribose) polymerase (PARP)-1,
and/or two cysteine proteases, calpains and cathepsins to yield
truncated AIF (tAIF) [14]. tAIF relocates from the mitochondria to
the cytosol and the nucleus, where it plays a key role in provoking
large-scale DNA degradation and chromatin condensation [13].
Oxidative damage, such as generation of reactive oxygen species
(ROS), has been shown to mediate PARP-1 activation and
lysosomal permeabilization, triggering cathepsin B release, mito-
chondrial dysfunction, and AIF release, which leads to caspase-
independent cell death [15,16].
Colon cancer is one of the leading causes of cancer death in the
developed world. Since the information regarding berberine’s
effects on colon cancer development is limited, the purpose of this
work was to investigate the mechanisms of action of berberine in
colon tumor cells. Here, we report that berberine induces ROS-
mediated stimulation of AIF activation through cathepsin B
release and PARP activation, which leads to caspase-independent
cell death in colon tumor cells. However, normal colon epithelial
cells are not as sensitive to berberine-induced cell death as colon
tumor cells. These findings suggest that berberine may provide
relative selectivity for colon cancer therapy, with less cytotoxic
effects on normal colon epithelial cells.
Results
Berberine Induces Cell Death and LDH Release in Colon
Tumor Cells
Berberine has been shown to suppress cell growth in tumor cell
lines through various mechanisms [7,8]. However, information
regarding the effect of berberine on colon cancer development is
limited. Thus, we determined the effects of berberine on colon
tumor cells. Familial adenomatous polyposis (FAP) can be caused
by germline mutations in the adenomatous polyposis coli (Apc)
tumor suppressor gene. The multiple intestinal neoplasia (Min)
mouse has a germline mutation in the Apc gene and develops
multiple polyps in the intestine. Thus, the Apc
min/+ mouse is an
animal model of human FAP [17]. We used mouse immorto-Min
colonic epithelium (IMCE) cells isolated from the colonic
epithelium of the Apc
min/+ mouse crossed with the Immortomouse
as a colon cancer cell model. Another colon tumor cell line, HT-29
cells, a human colon carcinoma cell line, was also studied. The
young adult mouse colonic epithelial (YAMC) cells were used to
assess berberine’s effects on normal colon epithelial cells.
We first detected the effects of berberine on tumor cell colony
formation. Overexpression the oncogene, ras, in IMCE (IMCE
ras )
cells promotes formation of colonies in agar. Co-culture of
berberine with IMCE
ras cells markedly decreased the colony
counts (Figure 1). These results indicate that berberine is capable
of inhibiting colon cancer cell growth.
To further determine the potential role of berberine in
regulating the fate of colon cell lines, we treated IMCE, HT-29,
and YAMC epithelial cells with berberine at 50 mM for 1, 3, 6, 18,
and 24 h and then analyzed cell viability. Berberine treatment for
18 h and 24 h resulted in a significant reduction of cell number in
IMCE cells (Figure 2A). When cells were treated with berberine at
12.5, 25, 50, 100 mM for 18 h, berberine treatment at 50 mM and
100 mM resulted in a significant induction of the death of IMCE
cell lines (Figure 2B).
The release of intracellular components, such as LDH, is
a marker for cell death. We therefore assessed whether treatment
of cells with berberine resulted in LDH release. Berberine
stimulated LDH release from IMCE cells in a time- and
concentration-dependent manner (Figure 2C–D).
In addition to IMEC cells, berberine induced cell death (Figure
S1A) and LDH release (Figure S1B) in HT-29 cells in
a concentration-dependent manner. Furthermore, berberine
showed significant increased effects on cell death when cells were
treated with berberine for 36 h, compared to 24 h treatment
(Figure S1C and S1D).
Notably, in YAMC cells, berberine did not induce cell death
(Figure 2A–B) or LDH release (Figure 2C–D) at 50 mM and
100 mM with 18 h or 24 h treatment. No loss of YAMC cells
detected using the cell viability assay was found when cells were
treated with berberine at concentrations from150 mM to 300 mM
(Figure S2A). Berberine at concentrations of higher than 150 mM
Figure 1. Berberine inhibits colon tumor colony growth in soft
agar. IMCE
ras cells were cultured in 0.35% agar on the basal 0.5% agar’s
layer in IMCE cell culture medium in the presence or absence of the
indicated concentrations of berberine at 33uC for 14 days. Prior to
counting colonies, cells were stained using the CellTiterH120 AQueou-
sOne Solution Cell Proliferation Assay. Colonies of .50 mm were
counted. The data are shown as fold increase in comparison with the
colony cultured without berberine (control). Data represent at least 3
independent experiments, each performed in triplicate. *p,0.01
compared to the control group, #p,0.01 compared to the 50 mMo f
the berberine treated group.
doi:10.1371/journal.pone.0036418.g001
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200 mM of berberine treatment on LDH release in YAMC cells
was observed at the similar levels as those induced by 50 mMo f
berberine treatment in IMCE cells. These data suggested that
colon tumor cells are more sensitive to cell death by berberine
treatment, compared to normal colon epithelial cells.
Berberine-induced Cell Death is Caspase-independent in
IMCE Cells
Since caspase-dependent apoptosis is the best-known modality
of programmed cell death, we determined whether berberine-
induced cell death is due to apoptosis in IMCE cells. We analyzed
caspase activation and PARP cleavage in cells treated with
berberine. None of the caspases, including caspase-3, caspase-6,
caspase-9, and caspase-12 were activated by berberine in IMCE
and YAMC cells (Figure 3A). In addition, berberine did not
stimulate cleavage of PARP (Figure 3A) in these two cell lines.
Cells were treated with TNF and cycloheximide as a positive
control for stimulating apoptosis. TNF and cycloheximide
cotreatment activated caspases-3, 6, 9 and 12 and stimulated
PARP cleavage in both IMCE and YAMC cells (Figure 3A).
Consistent with these data, berberine-stimulated cell death and
LDH release in IMCE cells were not blocked by the caspase
inhibitor, zVAD-fmk, in IMCE cells (Figure 3B–C). However,
zVAD-fmk inhibited TNF and cycloheximide-induced cell death
in both IMCE and YAMC cells (Figure 3B–C).
Berberine-induced cell death was also detected using Annexin V
and propidium iodide (PI) staining and flow cytometry. The cell
population with Annexin V positive and PI negative represents
cells in early apoptosis. The cell population with Annexin V
positive and PI positive is found in late apoptosis and in AIF-
mediated caspase-independent program cell death [18]. Positive
Annexin V staining never appears before permeabilization of the
plasma membrane (assessed by PI staining). Thus, there is no
Annexin V positive and PI negative cell population in caspase-
independent cell death. In agreement with these published results,
we found that berberine increased the cell population with
Annexin V positive and PI positive, but not the cell population
with Annexin V positive and PI negative (Figure S3). These data
indicate that berberine induced colon tumor cell death in
a caspase-independent manner.
Berberine-induced Caspase-independent Cell Death in
IMCE Cells Requires ROS Production
Berberine has been shown to stimulate ROS production in
several types of tumor cells to induce apoptosis [19,20]. However,
Figure 2. Berberine induces cell death and LDH release in the colon cancer cell line, IMCE cells. IMCE and YAMC cells were cultured in
serum-starved RPMI 1640 medium at 37uC (non-permissive condition) for 24 h with or without 50 mM berberine treatment for indicated times from
the end of experiment (A and C) or berberine treatment at indicated concentrations for 18 h (B and D). Cell viability was assessed using the
CellTiterH729 AQueousOne Solution Cell Proliferation Assay (A–B). % of cell number change was calculated as: [(cell number at the end of treatment-
cell number before treatment)/(cell number before treatment)]6100. Cell culture supernatants were collected for detecting LDH release using the
CytoTox 96H 159 Non-Radioactive Cytotoxicity Assay (C–D). LDH release is expressed as a percentage of control in each experiment. Data represent at
least 3 independent experiments, each performed in triplicate. *p,0.01 compared to the control group.
doi:10.1371/journal.pone.0036418.g002
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independent cell death [15,16]. Here, we determined whether
berberine-induced ROS production served as a possible upstream
mediator of caspase-independent cell death in IMCE cells. ROS
production was detected using dihydroethidium, a cell-permeable
fluorescence dye that reacts with a broad spectrum of ROS and is
analyzed by flow cytometry. The results showed that berberine
treatment resulted in an increase in ROS production in
a concentration-dependent manner only in IMCE cells, but not
in YAMC cells (Figure 4A). In addition to ROS production, we
measured mitochondrial membrane potential by staining cells with
JC1 dye. We found that berberine induced mitochondrial
depolarization in a concentration-dependent manner in IMCE
cells, but not in YAMC cells (Figure 4B).
We further detected the effects of berberine-induced ROS
production on cell death in IMEC cells. Tiron, a cell permeable
ROS scavenger, significantly down-regulated berberine-inducted
ROS level (Figure S4). Pretreatment of cells with Tiron decreased
cell death and release of LDH in IMCE cells treated with
berberine (Figure 4C–D). These data suggest that ROS generation
by berberine is required for colon tumor cell death. This
conclusion is further supported by the fact that no ROS
production and cell death (Figure 2) was observed in YAMC cells
treated with berberine.
Berberine Induces AIF Release from the Mitochondria
and Nuclear Translocation, Which is Required for Cell
Death in IMCE
As a consequence of ROS production, loss of mitochondrial
membrane potential may result in caspase-independent cell death.
To determine whether the mitochondrial pathway was involved in
induction of cell death by berberine, we examined the effect of
berberine on AIF activation. AIF is a mediator known to be
involved in the induction of the caspase-independent pathway.
AIF is released from mitochondria in response to death stimuli,
and subsequently, translocated into the nucleus leading to nuclear
condensation. We analyzed AIF localization by Western blotting
analysis of fractioned cellular components. Berberine treatment
induced AIF release to the cytosol and translocation to the nuclei
because AIF accumulated in the cytosolic and nuclear fractions,
and less AIF was found in the mitochondria (Figure 5A).
Moreover, immunofluorescence showed a granular pattern
(mitochondrial distribution) in control, whereas AIF was detected
in the nuclei upon berberine treatment in IMCE cells, but not in
YAMC cells (Figure 5B). Berberine-induced AIF activation was
also detected in HT-29 cells (Figure S5A).
To further study the role of AIF activation in berberine-induced
cell death, we knocked down AIF expression in IMCE cells by
transfecting AIF targeted siRNA (Figure 5C). We found that
down-regulation of AIF expression ameliorated cell death and
LDH release induced by berberine in IMCE cells, compared to
non-transfected cells or cells transfected with a non-targeting
siRNA (Figure 5D–E). These results indicate the requirement of
AIF release from the mitochondrial to cytoplasmic for berberine-
induced cell death in tumor cell lines.
Cathepsin B Release Mediates Berberine-stimulated AIF
Activation and Cell Death in IMCE Cells
Since several studies have reported that ROS production
induced permeabilization of lysosomes, we tested whether
berberine-induced ROS production could stimulate cathepsin-B
release. Immunofluorescence results confirmed that berberine
induced cathepsin-B release from the lysosome and nuclear
translocation in berberine-treated IMCE cells, but not YAMC
cells (Figure 6A). To investigate the role of ROS in AIF activation,
possibly through cathepsin B release from lysosomes, we
pretreated IMCE and YAMC cells with the ROS scavenger,
Figure 3. Berberine induces cell death through a caspase-
independent mechanism in IMCE cells. Cells were treated with
berberine at 50 mM for the indicated times or TNF (100 ng/ml) and
cycloheximide (1 mg/ml) for 6 h in serum-starved RPMI 1640 medium at
37uC, as described in Figure 2. Cellular lysates were collected for
Western blot analysis using antibodies against cleavage (active) forms
of caspases and an anti-PARP antibody (which identifies both intact and
cleavage forms) (A). The actin blot was used as a protein loading
control. Cells were treated with berberine at 50 mM for 18 h or TNF and
cycloheximide for 6 h in the presence or absence of a caspase inhibitor,
zVAD-fmk (25 mM). Cell number change (B) and LDH production (C)
were detected as described in Figure 2. *p,0.01 compared to the
control group. #p,0.01 compared to the TNF/cycloheximide treated
group.
doi:10.1371/journal.pone.0036418.g003
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berberine-induced cathepsin-B and AIF release into the cytosol
(Figure 6B). CA-074 Me pretreatment showed the same inhibitory
effect on berberine-induced cathepsin-B and AIF release
(Figure 6B). Furthermore, CA-074 Me decreased cell death and
LDH release induced by berberine in IMCE (Figure 6C–D) and in
HT-29 (Figure S5B and S5C) cells. These results indicate that
berberine-induced cathepsin B release mediates AIF activation
and caspase-independent cell death in colon tumor cells.
Berberine Activation of PARP Regulates AIF Activation
and Cell Death in IMCE Cells
Studies have shown that PARP activation is another target for
oxidative stress for stimulating AIF activation [21]. We tested
whether PARP activation was involved in the berberine-induced
mitochondrial AIF release in IMCE cells. Berberine activated
PARP in IMCE cells in a time- and concentration-dependent
manner (Figure 7A–B). The PARP activation inhibitor, DPG,
prevented berberine-induced cell death (Figure 7C) and LDH
release (Figure 7D) in IMEC and HT-29 (Figure S5B and S5C)
Figure 4. Berberine-induced ROS production is required for cell death in IMCE. Cells were treated with berberine at indicated
concentrations for 18 h (A and B), as described in Figure 2. Intracellular ROS levels were detected using DHE probe and the amount of fluorescence
was measured using flow cytometry. The fold change of the amount of fluorescence was calculated by comparing that in the treated groups to the
control group (A). Cells were treated with the JC-1 probe and then analyzed by flow cytometry to measures the fraction of cells with polarized or
depolarized mitochondrial membrane (B). Cells were treated with berberine at 50 mM for 18 h in the presence or absence of 5 mM of Tiron, a ROS
scavenger. Cell number change (C) and LDH release (D) were detected as described in Figure 2. *p,0.01 compared to the control group, #p,0.01
compared to the berberine treated group.
doi:10.1371/journal.pone.0036418.g004
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into the cytosol in IMCE cells (Figure 7E). Thus, activation of
PARP may serve a mechanism by which berberine induces
caspase-independent cell death through activation of AIF in colon
tumor cells.
Discussion
Considerable attention has been given to the identification of
naturally occurring chemopreventive or chemotherapeutic re-
agents capable of inhibiting or reversing the tumor development
process, including colon tumorigenesis. The evaluation of ancient
herbal products that have been widely used for other diseases may
provide insight into developing these herbs into new therapies for
cancer treatment. Berberine, which has been used to treat
bacteria-associated diarrhea, intestinal parasitic infections, and
ocular trachoma infections for several decades, represents one of
these herbs. In the present study, we showed that berberine
decreased colon tumor colony formation and induced caspase-
independent cell death in the IMCE colon tumor cell line. We
further showed that the mechanism underlying berberine-induced
cell death was through ROS-production-dependent AIF activa-
tion. Furthermore, two targets of ROS production in cells,
cathepsin B release from lysosomes and PARP activation, have
been shown to regulate AIF activation by berberine. Notably,
YAMC cells, a normal colon epithelial cell line, were not
susceptible to berberine-induced cell death and ROS production.
Therefore, these results suggest that berberine may prevent and/
or treat colon tumors through inducing caspase-independent cell
death, with potentially little, or no side effects on normal colon
cells.
The effects of berberine on inhibiting growth of a broad number
of tumor cell types have been reported through various
mechanisms, including suppressing proliferation and stimulating
caspase-dependent apoptosis, through regulating signaling path-
ways, such as p53, MAPK, and NF-kB [7,8]. The reported
Figure 5. Berberine stimulates AIF release from the mitochondria to the cytoplasm and nuclear translocation in IMCE, which is
required for berberine-induced cell death. Cells were treated with berberine at 50 mM for the indicated times, as described in Figure 2.
Cytoplasmic, nuclear, and mitochondrial fractions were prepared for Western blot analysis using anti-AIF, anti-GAPDH (cytosolic marker), anti-COX IV
(mitochondrial marker) and anti-Ki-67 (nuclear marker) antibodies (A). Immunostaining of cells with 50 mM berberine treatment for 18 h was
performed to localize AIF using an anti-AIF antibody and a FITC-conjugated secondary antibody (green) and nuclei using DAPI staining (blue). Arrows
indicate nuclei with AIF translocation (B). IMCE cells transfected with AIF siRNA or non-targeting siRNA for 24 h were treated with berberine at 50 mM
for 18 h to detect number change (D) and LDH release (E) as described in Figure 2. AIF expression levels were detected by Western blot analysis using
an anti-AIF antibody (C). Actin blot was used as a protein loading control. *p,0.01 compared to the control group.
doi:10.1371/journal.pone.0036418.g005
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effects is tumor cell line-specific. For example, berberine has been
reported to induce caspase-dependent apoptosis and disrupt
mitochondrial membrane potential to release cytochrome C and
AIF, which were prevented by overexpression of Bcl-XL, a signal
to preserve mitochondrial integrity, in a melanoma cell line SK-
MLE-2. Furthermore, results from this paper suggested that
MEK/ERK and B-Raf signaling pathways, but not ROS
production, were involved in berberine-induced apoptosis [22].
In our studies, when IMCE cells were treated with berberine,
there were no effects on p53, MAPK, or NF-kB pathways (data
not shown). A novel finding from our studies is the activation of
AIF by berberine leading to caspase-independent cell death and
the link between berberine-induced ROS generation and AIF
activation in colon tumor cells. These results reveal a new
mechanism for berberine’s action that may be important for colon
tumor prevention and treatment. However, it should be noted that
this may not be the sole mechanism for berberine’s activity in
colon tumor cells.
The clinical efficacy of chemotherapeutic drugs is largely
dependent on their ability to trigger tumor cell death, and
activation of apoptosis is one of the well-studied mechanisms
involved in this process. However, increasing evidence suggests
that there are forms of chemotherapy-induced cell death that are
different from apoptosis or necrosis [23]. Thus, strategies targeting
AIF-mediated caspase-independent cell death have been applied
as a therapeutic treatment for cancers. For example, a plant drug
from Scutellaria barbatae that stimulates AIF translocation from the
mitochondria to the nucleus showed anti-tumor effects in breast
cancer patients [24]. Since cathepsin release from lysosomes
regulates the AIF-mediated cell death pathway and several
members of the cathepsin family have been implicated in cancer
progression and metastasis [25,26], cathepsin is a potential target
to modulate caspase-independent cell death for cancer treatment.
For example, paclitaxel poliglumex, which triggers disruption of
the lysosomal integrity followed by cathepsin B release and cell
death, has shown efficacy for patients with advanced non-small cell
lung carcinoma in a phase III clinical trial [27]. Based on these
Figure 6. Berberine-stimulated cathepsin B release through ROS production is required for AIF activation in IMCE. Cells were treated
with berberine at 50 mM for 18 h in the presence or absence of a ROS scavenger, Tiron (5 mM) or a cathepsin B inhibitor, CA-074 Me (100 nM).
Immunostaining was performed to localize AIF using an anti-cathepsin B antibody and a FITC-conjugated secondary antibody (green) and nuclei
using DAPI staining (blue) (A). Cathepsin B staining shows granular lysosomal pattern in control cells and berberine treated YAMC cells and a diffuse
cytosolic pattern with more nuclear distribution after berberine treatment in IMCE cells. Cytoplasmic fractions were prepared for Western blot
analysis using anti-cathepsin B, anti-AIF, anti-GAPDH antibodies (B). Cell number change (C) and LDH release (D) were detected as described in
Figure 2. *p,0.01 compared to the control group, #p,0.01 compared to the berberine treated group.
doi:10.1371/journal.pone.0036418.g006
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considered for further studies as a promising candidate for colon
tumor prevention and treatment through modulating the AIF
pathway leading to caspase-independent cell death in colon tumor
cells.
Although caspase-dependent apoptosis plays a role in embry-
ologic development and pathogenesis of several diseases, evidence
suggests that death stimuli trigger alternative types of cell death in
these physiological and pathological processes, such as cell death
without the involvement of caspase activation. For example,
caspase inhibition by zVAD-fmk exacerbated TNF toxicity by
enhancing oxidative stress and mitochondrial damage, resulting in
kidney failure and death in mice, which suggested the pathophys-
iological relevance of caspase-independent, ROS-mediated path-
ways in response to lethal TNF-induced shock [28]. Although
berberine has been shown to induce caspase-dependent apoptosis
in tumor cells [7,8], it is also possible that the same stimulus can
trigger cell death through caspase-dependent and caspase-in-
dependent mechanisms in different cell lines. For example, FAS
ligand induced cell death in Jurkat cells in the absence of caspase
Figure 7. Berberine activates PARP in IMCE, which mediates berberine-mediated AIF activation and cell death. Cells were treated with
berberine at 50 mM for the indicated times (A) or at the indicated concentrations for 18 h (B). PARP activity was measured using the HT 167 Universal
Colorimetric PARP Assay Kit. PARP activation is expressed as a percentage of control in each experiment. Cells were treated with berberine at 50 mM
for 18 h in the presence or absence of DPG (25 mM), a PARP activation inhibitor. Cell number change (C) and LDH release (D) were detected as
described in Figure 2. The cytosolic fractions were prepared for Western blot analysis of AIF, as described in Figure 3 (E). *p,0.01 compared to the
control group, #p,0.01 compared to the berberine treated group.
doi:10.1371/journal.pone.0036418.g007
Caspase-Independent Tumor Cell Death by Berberine
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e36418activity, but caspase activity was required for FAS ligand-induced
cell death in other cells [29]. Our results in the current study
showed that the capase inhibitor, zVAD-fmk, suppressed cell
death induced by TNF and cycloheximide, but not berberine,
which is consistent with the result that TNF and cycloheximide,
but not berberine stimulated caspase activation. These findings
support our conclusion that berberine induces caspase-indepen-
dent cell death. However, several possibilities should be noted,
such as inefficiency of zVAD-fmk inhibition and the cytotoxicity of
this inhibitor, which can itself induce cell death. zVAD-fmk alone
did not stimulate cell death in ether IMCE or YAMC cells, and
while it may have the potential to increase berberine’s cytotoxicity,
we observed no such effect. In addition, the question of whether
caspase-independent cell death is the sole method for cell death in
berberine-treated tumor cells remains to be investigated. It is
possible that berberine-induced caspase-independent cell death
may trigger apoptosis in the later stage of berberine treatment.
ROS generation is implicated in the pathogenesis of many
chronic diseases, including cancer, and therefore, the potential side
effects of berberine-mediated ROS production should not be
ignored. One interesting finding from our studies is that normal
colon epithelial cells are less sensitive to berberine-induced cell
death, compared to colon tumor cells. In YAMC cells, berberine
did not induce ROS production (Figure 4), cell death (Figure 2A–
B) or LDH release, whereas these treatment conditions induced
cytotoxicity by ROS production in tumor cells. Berberine exerted
similar cytotoxic effects on prostate cancer cells [20] and inhibited
hepatoma cell invasion [30] through ROS production, but not in
normal prostate [20] and liver cells [30]. These results indicate
that normal cells, including colon epithelial cells, are resistant to
berberine-induced oxidative stress. We have performed further
experiments to investigate the mechanisms by which normal colon
epithelial cells are less sensitive to berberine, and found that that
absorption of berberine by YAMC is lower than that by IMCE
cells (Figure S6). Thus, colon tumor cells are potentially specific
targets of berberine.
In conclusion, the present study provides novel insight into the
mechanism of berberine-induced caspase-independent cell death
in both human and mouse colon tumor cells. These results will
serve as the basis for in vivo studies to investigate the effects of
berberine on colon tumor cancer development, which may make it
a promising new relative selective therapeutic approach for
colorectal cancer.
Materials and Methods
Cell Culture
YAMC is a conditionally immortalized murine colon epithelial
cell line isolated from the mouse harboring thermolabile mutation
(tsA58) under the control of an interferon (IFN)-c-inducible H-2K
b
promoter and a temperature-sensitive simian virus 40 large T
antigen (Immotomouse) [31]. The functional expression of the
SV40 large T antigen is induced by culturing the cells in vitro in
medium containing IFN c at a temperature permissive for function
of the tsA58 mutation (33uC). Expression of this gene is required
for YAMC cell proliferation. YAMC cells die when the
temperature is raised to the non-permissive temperature (37uC)
or when the cells are cultured without IFN-c for three passages.
The epithelial nature of YAMC cells has been characterized by
expression of keratin 18, a marker of epithelial cells. Although the
cells are morphologically primitive with no morphological
evidence of differentiation such as formation of a brush border
even when cultured at the non-permissive temperature, the
cultured cells retain some properties of the intestinal tissue of
origin, such as the presence of brush border associated enzymes,
alkaline phosphatase, dipeptidyl peptidase IV, and sucrase.
IMCE cell line was generated from the colonic epithelium of F1
Immorto-Apc
min/+ mouse hybrid [32]. Thus, IMCE cells carry
both the mutant Apc
min gene and a temperature-sensitive mutant
of the SV40 large T gene. YAMC and IMCE cell lines were
provided by Dr. Robert Whitehead at Vanderbilt University,
Nashville, TN.
YAMC and IMCE cells were maintained in RPMI 1640
medium supplemented with 5% fetal bovine serum (FBS), 5 U/ml
of murine IFN-c, 100 U/ml penicillin and streptomycin, 5 mg/ml
insulin, 5 mg/ml transferrin, 5 ng/ml selenous acid on collagen
coated plates at 33uC (permissive condition) with 5% CO2. HT-29
cells isolated from human colorectal adenocarcinoma (ATCC,
HTB-38
TM) were grown in DMEM medium supplemented with
10% FBS at 37uC.
For the berberine treatment in the presence or absence of
inhibitors, YAMC and IMCE cells were maintained in serum-
starved RPMI 1640 medium containing 0.5% FBS and 100 U/ml
penicillin and streptomycin (no IFN-c)a t3 7 uC (non-permissive
condition), and HT 29 cells were cultured in serum-starved
DMEM medium containing 0.5% FBS at 37uC.
Transient Transfection of siRNA
IMCE cells were transiently transfected with either 20 nM non-
targeting siRNA or 20 nM mouse AIF siRNA (Cell Signaling
Technology) at 80% confluence using Lipofectamine 2000
(Invitrogen Corporation), according to the manufacturer’s instruc-
tions. After 24 h transfection at 33uC (permissive condition), cells
were treated with berberine in serum-starved medium for 18 h at
37uC (non-permissive condition) for cell viability assay and LDH
release assay. Cellular lysates were collected at the end of the
experiment for Western blot analysis to determine the AIF
expression level.
Colony Formation Assay
IMCE cells with overexpression of v-Ha-ras gene (IMCE
ras)
were used to detect colon formation, as described previously [33].
Briefly, cells were prepared in 0.35% agar in IMCE cell culture
medium, and overlaid onto the basal agar’s layer (0.5% agar in
IMCE cell culture medium). Cells were cultured at 33uC
(permissive condition) with 5% CO2 for 14 days for growth of
colonies. Prior to count colonies, cells were stained using the
CellTiterH120 AQueousOne Solution Cell Proliferation Assay
(Promega) according to the manufacturer’s instructions. Colonies
of .50 mm were counted by an automated colony counter
(Biologics, Inc., Gainesville, VA).
Cell Viability Assay
5,000 cells/well were plated in 96-well plates and cultured
overnight to reach 70% confluence at 33uC (permissive condition)
for IMCE and YAMC cells and at 37uC for HT 29 cells in normal
medium. Then cells were treated with berberine in the presence or
absence of a cell permeable ROS scavenger, Tiron (4,5-dihydroxy-
1,3-benzenedisulfonic acid, Santa Cruz Biotechnology), a cell
permeable cathepsin B inhibitor, CA-074 Me (L-3-trans- (Pro-
pylcarbamoyl)oxirane-2-Carbonyl)-L-soleucyl-L-Proline Methyl
Ester, Enzo, Life Sciences), caspase inhibitor, zVAD-fmk (BD
Pharmingen
TM), a PARP inhibitor, 3,4-dihydro-5-[4-(1-piperidi-
nyl)butoxy]-1(2H)-isoquinolinone (DPQ), (Sigma-Aldrich), or a cell
permeable caspase inhibitor, Z-VAD-FMK (Promega), at 37uCi n
serum-starved medium for both IMCE and YAMC (non-
permissive condition) and HT 29 cells. Cell viability was assessed
using the CellTiterH120 AQueousOne Solution Cell Proliferation
Caspase-Independent Tumor Cell Death by Berberine
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cell number standard curve was generated to determine the cell
number in each treated group.
LDH Release Assay
Cells were cultured and treated as described in the cell viability
assay above. Cell culture supernatants were collected and LDH
release was measured using the CytoTox 96H Non-Radioactive
Cytotoxicity Assay (Promega) according to the manufacturer’s
instructions. Data were expressed as percentages of control values.
Detection of Mitochondrial Membrane Potential (Dy)
Dy was measured using the Flow Cytometry Mitochondrial
Membrane Potential Detection kit (BD
TM Mitoscreen) according
to the manufacturer’s instructions. Briefly, after treatment, cells
were resuspended in 0.5 mL of JC-1 solution and incubated at
37uC for 15 min. After rinsing, cells were analyzed by flow
cytometry. A dot plot of red fluorescence (living cells with intact
Dy) versus green fluorescence (cells with lost Dy) was recorded.
Data were expressed as percentage of cells with lost Dy.
Detection of Intracellular ROS Level
ROS production was detected using 29,79-dichlorofluorescein
diacetate (DCFH-DA) (Molecular Probe), according to the
manufacturer’s instructions. After treatment, cells were incubated
with 10 mM of DCFH-DA dye in PBS for 15 min and washed
with PBS 3 times. Fluorescence intensity of cells was analyzed
using flow cytometry. Data were expressed as percentages of
control values (DCF fluorescence in untreated cells).
PARP Activation Assay
PARP activity in cells was detected using the Universal
Colorimetric PARP Assay Kit (Trevigen, Inc., Gaithersburg,
MD) according to the manufacturer’s instructions. Data were
expressed as percentages of control values.
Preparation of Cytosolic, Nuclear and Mitochondrial
Fractions
Cells were scrapped in buffer-A containing 10 mmol/L Tris-
HCl (pH 8), 1.5 mmol/L MgCl2, 1 mmol/L EDTA, 1 mmol/L
1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane; dichlorodiphenyltri-
chloroethane (DDT), 1 mmol/L phenylmethylsulfonylfluoride,
5 mg/mL pepstatin-A, 1 mg/mL leupeptin, and 2 mg/mL aproti-
nin. After centrifugation at 3006g for 10 min, the supernatant was
saved as the cytosolic fraction. The cell pellet was resuspended in
buffer-A plus 0.1% Triton X-100, and incubated on ice for
10 min. After centrifugation at 12,0006g for 10 min, the
supernatant was saved as the mitochondrial fraction. The pellet
was resuspended in buffer-B containing 20 mmol/L Tris-HCl
(pH 8), 420 mmol/L NaCl, 1.5 mmol/L MgCl2, 1 mmol/L
EDTA, 1 mmol/L DDT, 25% glycerol, 1 mmol/L phenylmethyl-
sulfonyl-fluoride, 5 mg/mL pepstatin-A, 1 mg/mL leupeptin, and
2 mg/mL aprotinin, and agitated for 30 min at 4uC. The nuclear
fraction was collected after centrifugation at 20,2006g for 10 min.
Protein concentration was determined using a BCA protein assay
kit (Pierce Thermo, Scientific). GAPDH (cytosolic marker), Ki-67
(nuclear marker), and COX IV (mitochondrial marker) were used
to determine the purity of the fractions.
Western Blot Analysis
For preparing total cellular proteins, cell monolayers were
rinsed twice with cold PBS and then scraped into cell lysis buffer
(50 mM Tris-HCl (pH 7.4), 120 mM NaCl, 1% NP-40) with
protease and phosphatase 1 and 2 inhibitor cocktails (Sigma-
Aldrich). The scraped suspensions were centrifuged (14,0006g for
10 min) at 4uC, and the protein concentration was determined
using a BCA protein assay kit (Pierce Thermo, Scientific).
Equal amounts of total and fractionated proteins were mixed
with Laemmli sample buffer and separated by SDS-polyacryl-
amide gel electrophoresis for Western blot analysis using
antibodies against PARP (which identifies both un-cleaved
(116 kDa) and cleaved PARP, Cell Signaling), cleaved caspase 3
(Cell Signaling), cleaved caspase 6 (Cell Signaling), cleaved caspase
9 (Cell Signaling), cleaved caspase12 (Cell Signaling), AIF (Cell
Signaling), Cathepsin-B (Milipore), Ki-67 (Novocastra), GAPDH
(Cell Signaling), COXIV (Cell Signaling), and b-actin (Santa Cruz
Biotechnology).
Immunostaining
After treatment, cells were washed with PBS and fixed using 4%
paraformaldehyde for 15 min at room temperature. Cells were
permebilized using 2% Triton X-100 for 5 min in PBS at room
temperature and blocked in 3% bovine serum albumin in PBS
containing 1% Triton X-100 for 1 h at room temperature. Slides
were then incubated with anti-AIF antibody (Santa Cruz
Biotechnology) or anti-cathepsin B (Ab-1) monoclonal antibody
(Calbiochem) over night at 4uC and a FITC-labeled goat anti-
rabbit IgG (Zymed) antibody at room temperature for 1 h. Slides
were mounted using Vectashield
TM Mounting Medium containing
DAPI and observed using fluorescence microscopy. FITC and
DAPI images were taken from the same field.
Supporting Information
Figure S1 Berberine induces cell death and LDH release
in HT-29 cells. HT-29 cells were cultured in serum-starved
medium at 37uC for 24 h (A and B) or 36 h (C and D) with or
without berberine (50 mM) treatment for indicated times from the
end of experiment. Cell viability (A and C) and LDH release (B
and D) were detected as described in Figure 2. Data represent 3
independent experiments, each performed in triplicate. *p,0.01
compared to the control group.
(TIF)
Figure S2 High concentration of berberine induces LDH
release, but not cell loss, in YAMC cells. YAMC cells were
treated with berberine in serum-starved medium at 37uC for 24 h
at the indicated concentrations. Cell viability (A) and LDH release
(B) were detected as described in Figure 2. Data represent 3
independent experiments, each performed in triplicate. *p,0.01
compared to the control group.
(TIF)
Figure S3 Berberine-induced cell death in IMEC cells
was detected by Annexin V and propidium iodide (PI)
staining. IMEC ells were treated with berberine (50 mM) in
serum-starved medium at 37uC for 24 h. Then cells were
dissociated using accutase and double stained with Annxin V-
FITC and PI. The percentage of cells positive for Annexin V and
PI was detected by flow cytometry. Viable cells have low Annexin
V-FITC and low PI staining, early apoptotic cells have high
Annexin V-FITC and low PI staining, late apoptotic cells and
caspase-independent cell death have high Annexin V-FITC and
high PI staining, necrotic cells have low Annexin V-FITC and
high PI staining. The populations with high Annexin V (Annexin
V+) and low PI (PI-) and Annexin V+PI+ are shown. Data
represent 3 independent experiments, each performed in triplicate.
*p,0.01 compared to the control group.
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Figure S4 Tiron inhibits berberine-induced ROS pro-
duction in IMEC cells. Cells were treated with berberine
(50 mM) in serum-starved medium at 37uC for 18 h, as described
in Figure 2, in the presence or absence of a ROS scavenger, Tiron
(5 mM). Intracellular ROS levels were detected using DHE probe
and the amount of fluorescence was measured using flow
cytometry. The fold change of the amount of fluorescence was
calculated by comparing that in the treated groups to the control
group. Data represent 3 independent experiments, each per-
formed in triplicate. *p,0.01 compared to the control group,
#p,0.05 compared to the berberine only treated group.
(TIF)
Figure S5 Berberine stimulates AIF release in IMCE,
which is required for berberine-induced cell death in
HT29 cells. Cells were treated with berberine at 75 mMi n
serum-starved medium at 37uC for 24 h, as described in Figure 2.
Cytoplasmic, nuclear, and mitochondrial fractions were prepared
for Western blot analysis using anti-AIF, anti-GAPDH (cytosolic
marker), anti-COX IV (mitochondrial marker) and anti-Ki-67
(nuclear marker) antibodies (A). Cells were treated with berberine
at 75 mM for 24 h in the presence or absence of a ROS scavenger,
Tiron (5 mM), a cathepsin B inhibitor, CA-074 Me (100 nM), or
a PARP activation inhibitor, DPG (25 mM). Cell number change
(B) and LDH release (C) were detected as described in Figure 2.
Data represent 3 independent experiments, each performed in
triplicate. *p,0.01 compared to the control group, #p,0.01
compared to the berberine only treated group.
(TIF)
Figure S6 Absorption of berberine by IMEC and YAMC
cells. Cells were treated with berberine for 18 h at indicated
concentrations (A) or at 50 mM for indicated times (B), as
described in Figure 2. Cells were homogenized in PBS and the
cellular soluble protein concentration was determined. Berberine
content in the soluble fraction was determined by positive
ionization LC-MS/MS using canadine as an internal standard.
Data represent 3 independent experiments, each performed in
triplicate. *p,0.01 compared to the control group, #p,0.01
compared to YAMC cells with same concentration (A) or time (B)
of berberine treatment.
(TIF)
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